Lesley A. Stanley

2.4k total citations
41 papers, 1.7k citations indexed

About

Lesley A. Stanley is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Lesley A. Stanley has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Pharmacology and 13 papers in Oncology. Recurrent topics in Lesley A. Stanley's work include Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (10 papers) and Carcinogens and Genotoxicity Assessment (7 papers). Lesley A. Stanley is often cited by papers focused on Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (10 papers) and Carcinogens and Genotoxicity Assessment (7 papers). Lesley A. Stanley collaborates with scholars based in United Kingdom, United States and Denmark. Lesley A. Stanley's co-authors include C. Roland Wolf, Edith Sim, Nico Scheer, Peter C. Butler, Gerard A. Potter, Ketan C. Ruparelia, L. H. Patterson, M.D. Burke, P. B. Farmer and John H. Lamb and has published in prestigious journals such as PLoS ONE, Gut and Biochemical Journal.

In The Last Decade

Lesley A. Stanley

41 papers receiving 1.6k citations

Peers

Lesley A. Stanley

PHARM

ONCOL

GENET

Morag McFadyen United Kingdom

Gopalakrishnan Ramakrishnan United States

Rita Ghosh United States

Mark A. Morse United States

Syed Musthapa Meeran India

Saúl Villa‐Treviño Mexico

Komal Raina United States

Ni Ai United States

Fernando Moreno Spain

Chia‐Jui Weng Taiwan

Morag McFadyen United Kingdom

Lesley A. Stanley

813 ×1.1

849 ×1.9

PHARM

497 ×1.4

ONCOL

336 ×1.1

332 ×1.8

GENET

Citations per year, relative to Lesley A. Stanley Lesley A. Stanley (= 1×) peers Morag McFadyen

Countries citing papers authored by Lesley A. Stanley

Since Specialization

Citations

This map shows the geographic impact of Lesley A. Stanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley A. Stanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley A. Stanley more than expected).

Fields of papers citing papers by Lesley A. Stanley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley A. Stanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley A. Stanley. The network helps show where Lesley A. Stanley may publish in the future.

Co-authorship network of co-authors of Lesley A. Stanley

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley A. Stanley. A scholar is included among the top collaborators of Lesley A. Stanley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley A. Stanley. Lesley A. Stanley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

George, Jacob, James D. Chalmers, Colin J. Henderson, et al.. (2024). Use of an extensively humanized mouse model to predict the risk of drug–drug interactions in patients receiving dexamethasone. Journal of Pharmacology and Experimental Therapeutics. 392(2). 100053–100053. 2 indexed citations

Henderson, Colin J., et al.. (2015). Evidence That the Capacity of Nongenotoxic Carcinogens to Induce Oxidative Stress Is Subject to Marked Variability. Toxicological Sciences. 145(1). 138–148. 5 indexed citations

Henderson, Colin J., Lesley A. McLaughlin, Nico Scheer, Lesley A. Stanley, & C. Roland Wolf. (2015). Cytochrome b5 Is a Major Determinant of Human Cytochrome P450 CYP2D6 and CYP3A4 Activity In Vivo. Molecular Pharmacology. 87(4). 733–739. 30 indexed citations

Laurieri, Nicola, Julien Dairou, Lesley A. Stanley, et al.. (2014). From Arylamine N-Acetyltransferase to Folate-Dependent Acetyl CoA Hydrolase: Impact of Folic Acid on the Activity of (HUMAN)NAT1 and Its Homologue (MOUSE)NAT2. PLoS ONE. 9(5). e96370–e96370. 39 indexed citations

Laurieri, Nicola, Akane Kawamura, Isaac M. Westwood, et al.. (2014). Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding. BMC Pharmacology and Toxicology. 15(1). 68–68. 10 indexed citations

Stanley, Lesley A., et al.. (2009). Drug transporters: Gatekeepers controlling access of xenobiotics to the cellular interior. Drug Metabolism Reviews. 41(1). 27–65. 25 indexed citations

Hu, Ting, Ruth Bailey, Stephen W. Morrall, et al.. (2009). Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: Application of the EpiDerm™ human reconstructed epidermis model. Toxicology Letters. 188(2). 119–129. 47 indexed citations

Potter, Gerard A., L. H. Patterson, J. Jefferson P. Perry, et al.. (2002). The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. British Journal of Cancer. 86(5). 774–778. 316 indexed citations

Stanley, Lesley A., H. George Mandel, Joan Riley, et al.. (1999). Mutations associated with in vivo aflatoxin B1-induced carcinogenesis need not be present in the in vitro transformations by this toxin. Cancer Letters. 137(2). 173–181. 2 indexed citations

10.

Hickman, Dean, Shivakumar D. Patil, Giannoulis Fakis, et al.. (1998). Expression of arylamine N -acetyltransferase in human intestine. Gut. 42(3). 402–409. 114 indexed citations

11.

Stanley, Lesley A., et al.. (1998). Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain. Teratology. 58(5). 174–182. 52 indexed citations

12.

Stacey, Michael W., et al.. (1996). Arylarnine N-acetyltransferase as a potential biornarker in bladder cancer: fluorescent in situ hybridization and irnmunohistochernistry studies. Biomarkers. 1(1). 55–61. 6 indexed citations

13.

Stanley, Lesley A.. (1995). Molecular aspects of chemical carcinogenesis: The roles of oncogenes and tumour suppressor genes. Toxicology. 96(3). 173–194. 82 indexed citations

14.

Sim, Edith, Lesley A. Stanley, Angela Risch, & Peter Thygesen. (1995). Xenogenetics in multifactorial disease susceptibility. Trends in Genetics. 11(12). 509–512. 9 indexed citations

15.

Styles, J.A., Adrian Davies, C.K. Lim, et al.. (1994). Genotoxicity of tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis. 15(1). 5–9. 101 indexed citations

16.

Stanley, Lesley A., Dana Blackburn, Julie F. Foley, et al.. (1994). Ras mutations in methyiclofenapate-induced B6C3F1 and C57BL/1OJ mouse liver tumours. Carcinogenesis. 15(6). 1125–1131. 15 indexed citations

17.

Stanley, Lesley A., et al.. (1992). Cytochrome P‐450 induction in human lung tumor‐derived cell lines. European Journal of Biochemistry. 208(2). 521–529. 12 indexed citations

18.

Stanley, Lesley A., et al.. (1991). Differential effects of recombinant interferon α on constitutive and inducible cytochrome P450 isozymes in mouse liver. Biochemical Pharmacology. 42(2). 311–320. 42 indexed citations

19.

Gillam, Elizabeth M. J., et al.. (1990). Immunotoxic Side-Effects of Drug Therapy. Drug Safety. 5(3). 168–178. 14 indexed citations

20.

Sim, Edith, et al.. (1988). Metabolites of procainamide and practolol inhibit complement components C3 and C4. Biochemical Journal. 251(2). 323–326. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact